The American Diabetes Association, American Heart Association and American College of Cardiology issued a joint statement in June calling for tighter criteria in the use of aspirin as a primary prevention strategy against cardiovascular disease (CVD) for patients with diabetes. This represents a change from the recommendations issued in 2007. "The 2007 joint statement recommended that acetylsalicylic acid, commonly known as aspirin, be used as a primary prevention strategy in patients with diabetes mellitus over 40 years of age or with one or more additional cardiovascular risk factors," explains Leslie Cho, MD, editor-in-chief of Heart Advisor and director of the Womens Cardiovascular Center at Cleveland Clinic.
To continue reading this article or issue you must be a paid subscriber.
Sign in
